Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01369628 · ClinicalTrials.gov registry record · Phase 1
Atacicept in Lupus Nephritis Patients Taking Stable Regimen of Mycophenolate Mofetil
A Phase 1 study, sponsored by EMD Serono.
- Terminated
- Registry status
- Phase 1
- Development phase
- 1
- Enrollment target
NCT01369628: Clinical Trial Phase 1 study, sponsored by EMD Serono.
NCT01369628 is a Phase 1 study that was terminated before completion, run by EMD Serono. The registered enrollment target is 1 participants, below the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (98% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01369628, a Phase 1 study, was terminated before completion, sponsored by EMD Serono.
- TERMINATED
- Registry status
- Phase 1
- Development phase
- 1 participants
- Enrollment target
Study Summary
The sponsor electively terminated the study because the risk mitigation measures, deemed necessary after an unforeseen safety event, could not be effectively implemented within this protocol while maintaining study timelines within a reasonable time frame.
Primary Outcome
Frequency tables summarizing the observed number of AEs by System Organ Class (SOC) and preferred term will be presented per regimen.
Interventions
- DRUG Atacicept
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1 participants |
| Start Date | 2011-06 |
| Phase | Phase 1 |
Why NCT01369628 stopped before completion
NCT01369628 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 1 participants, a relatively small participant target, below the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (98% lower).
The record links to 0 conditions, and to 1 intervention - of which Atacicept is the first listed.
NCT01369628 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01369628 about?
NCT01369628 is a clinical study titled "Atacicept in Lupus Nephritis Patients Taking Stable Regimen of Mycophenolate Mofetil". The sponsor electively terminated the study because the risk mitigation measures, deemed necessary after an unforeseen safety event, could not be effectively implemented within this protocol while maintaining study timelines within a reasonable time frame.
What is the current status of trial NCT01369628?
This trial is currently terminated. It is a Phase 1 study. The enrollment target is 1 participants. The study started on 2011-06.
What interventions are being tested in trial NCT01369628?
The interventions under investigation include: Atacicept (DRUG).
Who is sponsoring clinical trial NCT01369628?
This trial is sponsored by EMD Serono, which has 71 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01369628's enrollment target sits among peer trials
1 2001st of 2000 the lowest of 2,000 other Phase 1 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 1 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia